US FDA Approves FoundationOne®CDx and FoundationOne®Liquid CDx as Companion Diagnostics for TALZENNA® (talazoparib) in Combination with XTANDI® (enzalutamide) to Identify ...

Foundation Medicine, Inc., a global, patient-focused precision medicine company, today announced that it has received approvals from the U.S. Food and Drug Administration (FDA) for FoundationOne®CDx ...

ASCO26: Talzenna and Xtandi combo has first-line promise in HRR altered-mCSPC

"ASCO26: Talzenna and Xtandi combo has first-line promise in HRR altered-mCSPC" was originally created and published by ...
Fierce Biotech

Foundation Medicine tallies FDA nod to pair its blood test with Pfizer’s prostate cancer combo

This time, it's Pfizer’s prostate cancer combo Talzenna (talazoparib) and Xtandi (enzalutamide), which can identify patients ...